EGFR and cancer: Therefore, identifying molecules that interact with the cytoplasmic domain of EGFR will contribute, not only to the elucidation of the regulatory mechanism of EGFR in cancer progression, but also to the development of new treatments for the uncontrolled growth of human cancers.